DOJ DOJ Announces Charges Against 36 For $1.2 Billion in Health Care Fraud Thomas Sullivan Sep 8, 2022 0 In July 2022, the United States Department of Justice (DOJ) announced criminal charges against three dozen defendants in thirteen…
CMS AMGA Urges CMS to Review the Good Faith Estimate Process Thomas Sullivan Sep 7, 2022 0 Earlier this summer, the American Medical Group Association (AMGA) sent a letter to the United States Centers for Medicare and…
Anti Kickback DOJ Reaches Settlement with California Doctor Over False Claims Act… Thomas Sullivan Sep 6, 2022 0 Earlier this year, Gerald M. Sacks, MD, reached a settlement agreement with the United States Department of Justice (DOJ) over…
Opioids Teva Announces $4.25 Billion Proposed Settlement Thomas Sullivan Sep 2, 2022 0 In late July 2022, Teva Pharmaceutical Industries announced a $4.25 billion proposed nationwide settlement to resolve thousands of…
CMS CMS Insurer Price Transparency Rule Now in Effect Thomas Sullivan Sep 1, 2022 0 On July 1, 2022, the “Transparency in Coverage” regulation aimed at health plans finally took effect after several years. The…
Drug Prices HHS OIG Finds that Eight Drug Codes Met CMS’ Price Substitution Criteria Thomas Sullivan Aug 31, 2022 0 Earlier this year, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) conducted a…
Opioids Allergan Reaches $2 Billion Settlement Over Improper Marketing of Opioids Thomas Sullivan Aug 30, 2022 0 AbbVie’s Allergan unit has allegedly reached an agreement to pay more than $2 billion to resolve lawsuits filed by state and local…
Medical Legal Centene Reaches $13.7 Million Settlement with New Mexico for Allegedly… Thomas Sullivan Aug 29, 2022 0 Earlier this year, Centene reached a $13.7 million settlement with the state of New Mexico over allegations that the company…
Compliance Policy and Medicine Compliance Update August 2022 Issue: Focus on 340B… Thomas Sullivan Aug 26, 2022 0 Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
FDA OPDP Works to Increase Transparency and Community Interaction Thomas Sullivan Aug 25, 2022 0 Throughout 2022, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) has made…